Seres Therapeutics Inc (MCRB) stock has gained 613.47% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives MCRB stock a score of 77 out of a possible 100.
That rank is mainly influenced by a long-term technical score of 100. MCRB's rank also includes a short-term technical score of 94. The fundamental score for MCRB is 37. In addition to the average rating from Wall Street analysts, MCRB stock has a mean target price of 34.75. This means analysts expect the stock to add 21.46% over the next 12 months.
What's Happening with MCRB Stock Today
Seres Therapeutics Inc (MCRB) stock is up 6.79% while the S&P 500 is lower by -0.41% as of 1:45 PM on Tuesday, Sep 29. MCRB has gained $1.82 from the previous closing price of $26.79 on volume of 784,266 shares. Over the past year the S&P 500 is up 12.13% while MCRB has gained 613.47%. MCRB lost -$1.07 per share in the over the last 12 months.
Click Here to get the full Stock Score Report on Seres Therapeutics Inc (MCRB) Stock.